February 4, 2022
Summary: Statistics from the past two years reflect an increasing concern with health and yet a decline in cancer screenings and even treatment. What will the impact be on employers in the immediate future as well as the longer term? How will workplaces need to adjust? What can employers do to encourage cancer prevention, detection, and treatment although Covid remains a concern?
Moderator: MaryLis Rich, President CEO Roundtable on Cancer – Gold Standard
- Otis W. Brawley, MD, Bloomberg Distinguished Professor, Oncology, Epidemiology, Johns Hopkins University. Also Member CEO Roundtable on Cancer Gold Standard Steering Committee and Health and Well-Being Consortium and Going for Gold Ambassador.
- Jen Mills, PhD, MPH, Vice President, Patient and Professional Partnerships at Foundation Medicine
- Joya Delgado-Harris, MPH, Executive Director, CEO Roundtable on Cancer Gold Standard and Going for Gold Ambassador